Pluxee


Strong Q3 and maintained guidance support our Buy idea

03/07/25 -"Pluxee’s Q3 revenue met expectations and was on track towards the unchanged FY guidance, aiming to continue benefiting from its active M&A strategy. We reiterate our Buy recommendation. For ..."

Pages
60
Language
English
Published on
03/07/25
You may also be interested by these reports :
13/01/26
We have materially lowered our target price while maintaining a constructive long-term outlook. This downward revision mainly reflects the recent ...

07/01/26
Q1 revenue was aligned with consensus, with uneven geographic performance: Continental Europe faced macro headwinds and delivered modest growth, ...

06/01/26
Benefitting from elevated inflation and interest rates, which support higher issuance volumes and float income, Edenred (BUY ; France) reached an ...

05/01/26
With no near-term visibility on Edenred’s joint appeals against the recent regulatory changes in Italy and Brazil, we have finally revised our ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO